Using deep-neural-network-driven facial recognition to identify distinct Kabuki syndrome 1 and 2 gestalt.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
06 2022
Historique:
received: 01 04 2021
accepted: 25 10 2021
revised: 06 10 2021
pubmed: 23 11 2021
medline: 11 6 2022
entrez: 22 11 2021
Statut: ppublish

Résumé

Kabuki syndrome (KS) is a rare genetic disorder caused by mutations in two major genes, KMT2D and KDM6A, that are responsible for Kabuki syndrome 1 (KS1, OMIM147920) and Kabuki syndrome 2 (KS2, OMIM300867), respectively. We lack a description of clinical signs to distinguish KS1 and KS2. We used facial morphology analysis to detect any facial morphological differences between the two KS types. We used a facial-recognition algorithm to explore any facial morphologic differences between the two types of KS. We compared several image series of KS1 and KS2 individuals, then compared images of those of Caucasian origin only (12 individuals for each gene) because this was the main ethnicity in this series. We also collected 32 images from the literature to amass a large series. We externally validated results obtained by the algorithm with evaluations by trained clinical geneticists using the same set of pictures. Use of the algorithm revealed a statistically significant difference between each group for our series of images, demonstrating a different facial morphotype between KS1 and KS2 individuals (mean area under the receiver operating characteristic curve = 0.85 [p = 0.027] between KS1 and KS2). The algorithm was better at discriminating between the two types of KS with images from our series than those from the literature (p = 0.0007). Clinical geneticists trained to distinguished KS1 and KS2 significantly recognised a unique facial morphotype, which validated algorithm findings (p = 1.6e-11). Our deep-neural-network-driven facial-recognition algorithm can reveal specific composite gestalt images for KS1 and KS2 individuals.

Identifiants

pubmed: 34803161
doi: 10.1038/s41431-021-00994-8
pii: 10.1038/s41431-021-00994-8
pmc: PMC9177756
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

682-686

Informations de copyright

© 2021. The Author(s), under exclusive licence to European Society of Human Genetics.

Références

Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet. 2010;42:790–3.
doi: 10.1038/ng.646
Lederer D, Grisart B, Digilio MC, Benoit V, Crespin M, Ghariani SC, et al. Deletion of KDM6A, a Histone Demethylase Interacting with MLL2, in Three Patients with Kabuki Syndrome. Am J Hum Genet. 2012;90:119–24.
doi: 10.1016/j.ajhg.2011.11.021
Miyake N, Mizuno S, Okamoto N, Ohashi H, Shiina M, Ogata K, et al. KDM6A point mutations cause Kabuki syndrome. Hum Mutat. 2013;34:108–10.
doi: 10.1002/humu.22229
Bögershausen N, Gatinois V, Riehmer V, Kayserili H, Becker J, Thoenes M, et al. Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2. Hum Mutat. 2016;37:847–64.
doi: 10.1002/humu.23026
Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BWM, Willemsen MH, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511:344–7.
doi: 10.1038/nature13394
Zou J, Huss M, Abid A, Mohammadi P, Torkamani A, Telenti A. A primer on deep learning in genomics. Nat Genet. 2018. https://doi.org/10.1038/s41588-018-0295-5
Liehr T, Acquarola N, Pyle K, St-Pierre S, Rinholm M, Bar O, et al. Next generation phenotyping in Emanuel and Pallister-Killian syndrome using computer-aided facial dysmorphology analysis of 2D photos. Clin Genet. 2018;93:378–81.
doi: 10.1111/cge.13087
Basel-Vanagaite L, Wolf L, Orin M, Larizza L, Gervasini C, Krantz ID, et al. Recognition of the Cornelia de Lange syndrome phenotype with facial dysmorphology novel analysis. Clin Genet. 2016;89:557–63.
doi: 10.1111/cge.12716
Hadj-Rabia S, Schneider H, Navarro E, Klein O, Kirby N, Huttner K, et al. Automatic recognition of the XLHED phenotype from facial images. Am J Med Genet A. 2017;173:2408–14.
doi: 10.1002/ajmg.a.38343
Hurst ACE. Facial recognition software in clinical dysmorphology. Curr Opin Pediatr. 2018;30:701–6.
doi: 10.1097/MOP.0000000000000677
Pantel JT, Zhao M, Mensah MA, Hajjir N, Hsieh T-C, Hanani Y, et al. Advances in computer-assisted syndrome recognition by the example of inborn errors of metabolism. J Inherit Metab Dis. 2018;41:533–9.
doi: 10.1007/s10545-018-0174-3
Dudding-Byth T, Baxter A, Holliday EG, Hackett A, O’Donnell S, White SM, et al. Computer face-matching technology using two-dimensional photographs accurately matches the facial gestalt of unrelated individuals with the same syndromic form of intellectual disability. BMC Biotechnol. 2017;17:90.
doi: 10.1186/s12896-017-0410-1
Moon J-E, Lee S-J, Ko CW. A de novo KMT2D mutation in a girl with Kabukisyndrome associated with endocrine symptoms: a case report. BMC Med Genet. 2018;19:102.
doi: 10.1186/s12881-018-0606-9
Li Y, Bögershausen N, Alanay Y, Simsek Kiper PO, Plume N, Keupp K, et al. A mutation screen in patients with Kabuki syndrome. Hum Genet déc. 2011;130:715–24.
doi: 10.1007/s00439-011-1004-y
Mısırlıgil M, Yıldız Y, Akın O, Odabaşı Güneş S, Arslan M, Ünay B. A Rare Cause of Hyperinsulinemic Hypoglycemia: Kabuki Syndrome. J Clin Res Pediatr Endocrinol. 2020. Online ahead of print.
Lederer D, Shears D, Benoit V, Verellen-Dumoulin C, Maystadt I. A three generation X-linked family with Kabuki syndrome phenotype and a frameshift mutation in KDM6A. Am J Med Genet A. 2014;164A:1289–92.
doi: 10.1002/ajmg.a.36442
So PL, Luk HM, Yu KPT, Cheng SSW, Hau EWL, Ho SKL, et al. Clinical and molecular characterization study of Chinese Kabuki syndrome in Hong Kong. Am J Med Genet A. 2021;185:675–86.
doi: 10.1002/ajmg.a.62003
Dentici ML, Di Pede A, Lepri FR, Gnazzo M, Lombardi MH, Auriti C, et al. Kabuki syndrome: clinical and molecular diagnosis in the first year of life. Arch Dis Child. 2015;100:158–64.
doi: 10.1136/archdischild-2013-305858
Banka S, Lederer D, Benoit V, Jenkins E, Howard E, Bunstone S, et al. Novel KDM6A (UTX) mutations and a clinical and molecular review of the X-linked Kabuki syndrome (KS2). Clin Genet. 2015;87:252–8.
doi: 10.1111/cge.12363
Gurovich Y, Hanani Y, Bar O, Nadav G, Fleischer N, Gelbman D, et al. Identifying facial phenotypes of genetic disorders using deep learning. Nat Med. 2019;25:60–4.
doi: 10.1038/s41591-018-0279-0
Van der Donk R, Jansen S, Schuurs-Hoeijmakers JHM, Koolen DA, Goltstein LCMJ, Hoischen A, et al. Next-generation phenotyping using computer vision algorithms in rare genomic neurodevelopmental disorders. Genet Med. 2018. https://doi.org/10.1038/s41436-018-0404-y

Auteurs

Flavien Rouxel (F)

Montpellier University, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Centre de référence anomalies du développement SOOR, INSERM U1183, Montpellier, France.

Kevin Yauy (K)

Montpellier University, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Centre de référence anomalies du développement SOOR, INSERM U1183, Montpellier, France.

Guilaine Boursier (G)

Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique des Maladies Rares et Auto-inflammatoires, CHU Montpellier, Université de Montpellier, Montpellier, France.

Vincent Gatinois (V)

Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, laboratoire de génétique chromosomique, CHU Montpellier, Université de Montpellier, Montpellier, France.

Mouna Barat-Houari (M)

Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique des Maladies Rares et Auto-inflammatoires, CHU Montpellier, Université de Montpellier, Montpellier, France.

Elodie Sanchez (E)

Montpellier University, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Centre de référence anomalies du développement SOOR, INSERM U1183, Montpellier, France.

Didier Lacombe (D)

Service de génétique médicale, Centre de référence anomalies du développement SOOR, CHU Bordeaux, INSERM U1211, Université de Bordeaux, Bordeaux, France.

Stéphanie Arpin (S)

Service de Génétique, CHU Tours, UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.

Fabienne Giuliano (F)

Service de Médecine Génétique, CHUV, Université de Lausanne, Lausanne, France.

Damien Haye (D)

Génétique médicale, Hôpital Robert Debré, APHP, Paris, France.
Génétique médicale, Hôpital Pitié-Salpétrière, APHP, Paris, France.

Marlène Rio (M)

Fédération de génétique, et Institut Imagine, UMR-1163, Hôpital Universitaire Necker-Enfants Malades, APHP, Paris, France.

Annick Toutain (A)

Service de Génétique, CHU Tours, UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.

Klaus Dieterich (K)

Service de Génétique Médicale, CHU Grenoble Alpes, Univ. Grenoble Alpes, Inserm, U1216, GIN, 38000, Grenoble, France.

Elise Brischoux-Boucher (E)

Centre de Génétique Humaine, Université de Franche-Comté, Besançon, France.

Sophie Julia (S)

Service de génétique clinique, CHU Toulouse, Toulouse, France.

Mathilde Nizon (M)

CHU Nantes, Service de Génétique Médicale, 9 quai Moncousu, 44093, Nantes, CEDEX 1, France.

Alexandra Afenjar (A)

APHP, Département de génétique, Sorbonne Université, GRC n°19, ConCer-LD, Centre de Référence déficiences intellectuelles de causes rares, Hôpital Armand Trousseau, F-75012, Paris, France.

Boris Keren (B)

Génétique médicale, Hôpital Pitié-Salpétrière, APHP, Paris, France.

Aurelia Jacquette (A)

Génétique médicale, Hôpital Pitié-Salpétrière, APHP, Paris, France.

Sebastien Moutton (S)

Centre Pluridisciplinaire de Diagnostic PréNatal, Pôle mère enfant, Maison de Santé Protestante Bordeaux Bagatelle, 33400, Talence, France.

Marie-Line Jacquemont (ML)

Génétique médicale, CHU Réunion, Réunion, France.

Claire Duflos (C)

Département d'information médicale, CHU de Montpellier, Montpellier, France.

Yline Capri (Y)

Génétique médicale, Hôpital Robert Debré, APHP, Paris, France.

Jeanne Amiel (J)

Fédération de génétique, et Institut Imagine, UMR-1163, Hôpital Universitaire Necker-Enfants Malades, APHP, Paris, France.

Patricia Blanchet (P)

Montpellier University, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Centre de référence anomalies du développement SOOR, INSERM U1183, Montpellier, France.

Stanislas Lyonnet (S)

Fédération de génétique, et Institut Imagine, UMR-1163, Hôpital Universitaire Necker-Enfants Malades, APHP, Paris, France.

Damien Sanlaville (D)

Service de Génétique, HFME, CHU Lyon, Lyon, France.

David Genevieve (D)

Montpellier University, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Centre de référence anomalies du développement SOOR, INSERM U1183, Montpellier, France. d-genevieve@chu-montpellier.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH